Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and older with moderate to severe atopic dermatitis.
Chris Lange The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
As of the most recently reported period, short sellers still favored Pfizer, Intel and Microsoft above all other Dow stocks.
Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas, 10 tied mostly to retailing of apparel and accessories, and six are…
GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction with Pfizer.
Chris Lange The top analyst upgrades, downgrades and initiations seen on Tuesday included Cisco Systems, Duke Energy, Goodyear, Illumina, Kinder Morgan, Micron Technology, Pfizer and Tencent Music.
Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of the Dow Jones industrials that are reporting this week, but they make…
Mylan released its second-quarter financial results before the markets opened on Monday. The pharma giant also announced a major update to its business involving Pfizer and that CEO Heather Bresch is resigning.
